Pan-cancer analysis of PIEZO1: a promising biomarker for diagnosis, prognosis, and targeted therapies
Our findings indicate that PIEZO1 is a promising marker for the diagnosis, prognosis, and development of targeted pan-cancer therapies.
Authors
- Dan Wan (ORCID: https://orcid.org/0000-0002-7474-6855)
- Pengpeng Zhu (ORCID: https://orcid.org/0000-0003-2583-5437)
- Liang Xiao (ORCID: https://orcid.org/0000-0003-0312-7149)
- Yu Yan (ORCID: https://orcid.org/0009-0009-6168-9933)
- Ke Du (ORCID: https://orcid.org/0000-0002-8043-6562)
- Qian Wang (ORCID: https://orcid.org/0009-0006-7421-1451)
Institutions
- Nantong University (CN)
- The Affiliated Taizhou People's Hospital of Nanjing Medical University (CN)
- Second Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-09-04
- DOI
- https://doi.org/10.3389/fimmu.2025.1625734
- Citations
- 4
- Primary Topic
- Erythrocyte Function and Pathophysiology
- Type
- article
- Field-Weighted Citation Impact
- 4.66